Sillen, Machteld <br/><br/>
Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  03 2020 
 - 681-692 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/jth.14716  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Plasminogen Activator Inhibitor 1<br/>Plasminogen Activators<br/>Single-Domain Antibodies<br/>Tissue Plasminogen Activator<br/>Urokinase-Type Plasminogen Activator<br/>Vitronectin